Reshma Kewalramani
CIK 1735944 · CEO & President · last filed 2026-03-03
Reshma Kewalramani is a CEO & President who has filed 65 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing shows the insider sold $19.7M of VRTX on Mar 3, 2026. Across all open-market trades the lifetime net is −$74.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $56.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$56.77M
2
65
-$74.81M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRTX | CEO & President | 127,596 | $444.93 | $56.77M | -$74.81M | 59 | 2026-03-03 |
| Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Director | 186,002 | $0.01 | $1.2K | $0 | 6 | 2024-06-14 |
Recent Filings
65 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-03 | VRTX | Sell (S) | −40,000 | -$19.74M | EDGAR |
| 2026-02-26 | VRTX | Tax (F) | −4,981 | -$2.42M | EDGAR |
| 2026-02-19 | VRTX | Mixed | +9,772 | -$3.17M | EDGAR |
| 2026-02-18 | VRTX | Tax (F) | −13,041 | -$6.36M | EDGAR |
| 2026-02-12 | VRTX | Tax (F) | −8,297 | -$3.89M | EDGAR |
| 2026-01-26 | VRTX | Grant (A) | +38,857 | $0 | EDGAR |
| 2025-08-07 | VRTX | Buy (P) | +10,000 | $3.90M | EDGAR |
| 2025-02-28 | VRTX | Tax (F) | −14,079 | -$6.75M | EDGAR |
| 2025-02-26 | VRTX | Tax (F) | −9,386 | -$4.54M | EDGAR |
| 2025-02-19 | VRTX | Tax (F) | −6,553 | -$3.04M | EDGAR |